Oncology Institute, Inc.

The Oncology Institute, Inc., trading under the ticker TOI, is a value-based oncology care company that entered the public markets through a SPAC merger with DFB Healthcare Acquisitions Corp., a blank-check vehicle sponsored by DFB Healthcare and focused on the healthcare sector. DFB Healthcare Acquisitions Corp. completed its IPO in 2020, targeting acquisitions within the broad healthcare industry. The company filed a Form 10-Q with the SEC on May 28, 2021, under accession number 0001104659-21-073662, providing a quarterly update during the pre-merger transition period. TOI operates community-based oncology practices across the United States, positioning itself as a data-driven provider within the specialty healthcare space. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC analytics on TOI and hundreds of other de-SPAC transactions.